158 related articles for article (PubMed ID: 12752223)
1. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
Zacchetti A; van Garderen E; Teske E; Nederbragt H; Dierendonck JH; Rutteman GR
APMIS; 2003 Mar; 111(3):430-8. PubMed ID: 12752223
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical identification method of tumour cells in the S phase of mitotic cycle and its usefulness in diagnostics of mammary gland adenocarcinomas in bitches.
Nowak M; Madej JA; Dziegiel P; Kanzawa H
Pol J Vet Sci; 2006; 9(1):57-62. PubMed ID: 16573276
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression.
Sakai H; Noda A; Shirai N; Iidaka T; Yanai T; Masegi T; Shirai N; Iidaka T; Yanai T; Masegi T
J Comp Pathol; 2002 Nov; 127(4):233-8. PubMed ID: 12443730
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.
Tinnemans MM; Lenders MH; ten Velde GP; Wagenaar SS; Blijham GH; Ramaekers FC; Schutte B
Virchows Arch; 1995; 427(3):295-301. PubMed ID: 7496600
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.
Muskhelishvili L; Latendresse JR; Kodell RL; Henderson EB
J Histochem Cytochem; 2003 Dec; 51(12):1681-8. PubMed ID: 14623936
[TBL] [Abstract][Full Text] [Related]
9. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
Löhr CV; Teifke JP; Failing K; Weiss E
Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
[TBL] [Abstract][Full Text] [Related]
12. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H
Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347
[TBL] [Abstract][Full Text] [Related]
13. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
14. In situ analysis of cellular proliferation in canine, feline and equine tumors by immunohistochemistry: a comparison of bromodeoxyuridine, proliferating cell nuclear antigen, and interchromatin-associated antigen immunostaining techniques.
Théon AP; Metzger L; Griffey S
J Vet Diagn Invest; 1994 Oct; 6(4):453-7. PubMed ID: 7858025
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours.
Rodrigues H; Carvalho MI; Pires I; Prada J; Queiroga FL
Acta Vet Hung; 2016 Mar; 64(1):78-89. PubMed ID: 26919145
[TBL] [Abstract][Full Text] [Related]
16. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
18. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours.
Preziosi R; Sarli G; Benazzi C; Marcato PS
J Comp Pathol; 1995 Nov; 113(4):301-13. PubMed ID: 8746954
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige SR; Butterworth BE; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
[TBL] [Abstract][Full Text] [Related]
20. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa.
Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS
Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
